H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
HOM - Homeland Security DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE
EMERGENT BIOSOLUTIONS INC.
1455 Pennsylvania Avenue, NW, SUITE 1225, Washington, DC, 20004, US
CHRIS FRECH JILL HAMAKER KATHERINE GETTY CHRIS FRECH JILL HAMAKER KATHERINE GETTY KATHERINE GETTY JILL HAMAKER CHRIS FRECH CHRIS FRECH JILL HAMAKER KATHERINE GETTY